News

There's new uncertainty about updated COVID-19 shots this fall after the Trump administration's handling of a shot from ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
Federal regulators have requested that Novavax conduct an additional randomized clinical trial of its COVID-19 vaccine, a costly demand that could threaten the company’s ability to comply, The Wall ...
Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.